Optilume BPH Catheter System
FDA premarket approval P220029 · decided 2023-06-30
Approval details
- PMA number
- P220029
- Trade name
- Optilume BPH Catheter System
- Generic name
- Drug coated prostatic dilation catheter for benign prostatic hyperplasia
- Applicant
- Urotronic, Inc.
- Date received
- 2022-12-12
- Decision date
- 2023-06-30
- Days to decision
- 200 days
- Decision code
- APPR
- Product code
- QXB
- Advisory committee
- Gastroenterology, Urology
- Expedited review
- No
- Location
- Minneapolis, MN
- Statement
- Approval for the Optilume BPH Catheter System indicated for the treatment of obstructive urinary symptoms associated with Benign Prostatic Hyperplasia (BPH) in men >= 50 years of age.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.
510(k) clearances by this applicant
| Record | Firm | Date |
|---|---|---|
| Optilume® High Pressure Urological Balloon Dilation Catheter (K250910) | Urotronic, Inc. | 2025-05-22 |
| Optilume Basic Urological Balloon Dilation Catheter (K191061) | Urotronic, Inc. | 2020-01-02 |